CGON
Price:
$72.39
Market Cap:
$6.38B
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent;...[Read more]
Industry
Biotechnology
IPO Date
2024-01-25
Stock Exchange
NASDAQ
Ticker
CGON
According to CG Oncology Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.36B. This represents a change of 83.00% compared to the average of 3.47B of the last 4 quarters.
The mean historical Enterprise Value of CG Oncology Inc. over the last ten years is 2.41B. The current 6.36B Enterprise Value has changed 26.32% with respect to the historical average. Over the past ten years (40 quarters), CGON's Enterprise Value was at its highest in in the March 2026 quarter at 5.69B. The Enterprise Value was at its lowest in in the June 2023 quarter at 0.
Average
2.41B
Median
2.44B
Minimum
1.54B
Maximum
3.18B
Discovering the peaks and valleys of CG Oncology Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 107.36%
Maximum Annual Enterprise Value = 3.18B
Minimum Annual Increase = -37.82%
Minimum Annual Enterprise Value = 1.54B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 3.18B | 107.36% |
| 2024 | 1.54B | -37.82% |
| 2023 | 2.47B | 2.70% |
| 2022 | 2.40B | -1.38% |
The current Enterprise Value of CG Oncology Inc. (CGON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.40B
5-year avg
2.41B
10-year avg
2.41B
CG Oncology Inc.’s Enterprise Value is greater than Celcuity Inc. (4.63B), less than Ascentage Pharma Group International (10.02B), greater than Centessa Pharmaceuticals plc (6.21B), less than Apogee Therapeutics, Inc. (7.86B), greater than Xenon Pharmaceuticals Inc. (5.71B), greater than Travere Therapeutics, Inc. (6.31B), greater than Ultragenyx Pharmaceutical Inc. (2.34B), greater than Legend Biotech Corporation (3.30B), greater than Disc Medicine, Inc. (2.95B), greater than Tarsus Pharmaceuticals, Inc. (2.59B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 4.63B | $4.58B | |
| 10.02B | $1.56B | |
| 6.21B | $6.27B | |
| 7.86B | $8.30B | |
| 5.71B | $6.24B | |
| 6.31B | $5.81B | |
| 2.34B | $2.47B | |
| 3.30B | $3.56B | |
| 2.95B | $2.99B | |
| 2.59B | $2.61B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CG Oncology Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CG Oncology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CG Oncology Inc.'s Enterprise Value?
What is the highest Enterprise Value for CG Oncology Inc. (CGON)?
What is the 3-year average Enterprise Value for CG Oncology Inc. (CGON)?
What is the 5-year average Enterprise Value for CG Oncology Inc. (CGON)?
How does the current Enterprise Value for CG Oncology Inc. (CGON) compare to its historical average?